Outcome of Cenegermin in the Treatment of Neurotrophic Keratopathy
Cenegermin is an effective treatment of NK in the clinical setting, although a notable proportion of patients experience disease recurrence subsequently. Mackie staging is a significant prognostic factor for treatment success.
Authors
- Saba Al-Hashimi (ORCID: https://orcid.org/0000-0001-9957-4511)
- Anthony John Aldave (ORCID: https://orcid.org/0000-0002-9082-4796)
- S. Fung (ORCID: https://orcid.org/0000-0001-9905-636X)
- Seyed Reza Ghaffari
- Golshan Latifi (ORCID: https://orcid.org/0000-0003-3060-772X)
- Piseth Dalin Chea (ORCID: https://orcid.org/0000-0003-4042-2307)
Institutions
- University of California, Los Angeles (US)
- The University of Texas at San Antonio Health Science Center (US)
- University of California, San Francisco (US)
- Royal University of Fine Arts (KH)
- The University of Texas at San Antonio (US)
Publication Details
- Journal
- Cornea
- Published
- 2025-10-27
- DOI
- https://doi.org/10.1097/ico.0000000000004024
- Primary Topic
- Ocular Surface and Contact Lens
- Type
- article
- Field-Weighted Citation Impact
- 0.00